Search research articles
Contact Us
Filters
Showing results (91-100 of 132) with videos related to
Page
of 14
Sort By:
Resuscitation
|
November 16, 2013
Cerebrospinal fluid biomarkers in cardiac arrest survivors
Christoffer Rosén, Hans Rosén, Ulf Andreasson, et al.
Journal of Neuroinflammation
|
May 14, 2013
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
Aylin Yilmaz, Constantin T Yiannoutsos, Dietmar Fuchs, et al.
Journal of Neuroinflammation
|
January 26, 2019
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
Linn Hermansson, Aylin Yilmaz, Markus Axelsson, et al.
Brain Communications
|
November 7, 2022
The effect of vitamin B supplementation on neuronal injury in people living with HIV: a randomized controlled trial
Erika Tyrberg, Lars Hagberg, Lars-Magnus Andersson, et al.
BMC Infectious Diseases
|
April 23, 2016
Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study
Sofie Jespersen, Karin Kæreby Pedersen, Birgitta Anesten, et al.
Journal of Affective Disorders
|
October 17, 2020
Cost-effectiveness of an indicated preventive intervention for depression in adolescents: a model to support decision making
Richard Ssegonja, Filipa Sampaio, Iman Alaie, et al.
Journal of Neuroimmunology
|
February 6, 2025
Cerebrospinal fluid biomarkers associated with neurofilament light levels: A study in HIV disease
Enrico Ripamonti, Magnus Gisslén, Lars Hagberg, et al.
Plos One
|
February 14, 2014
Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients
Jan Jessen Krut, Tomas Mellberg, Richard W Price, et al.
BMJ Open
|
November 1, 2022
Digitally distributed Yoga Intervention in Breast Cancer Rehabilitation (DigiYoga CaRe): protocol for a randomised controlled trial
Emma Ohlsson Nevo, MiaLinn Arvidsson-Lindvall, Susanne Hellerstedt Börjeson, et al.
Virulence
|
July 21, 2016
No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau)
Jan J Krut, Richard W Price, Henrik Zetterberg, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 132) with videos related to
Sort By:
Page
of 14
Resuscitation
|
November 16, 2013
Cerebrospinal fluid biomarkers in cardiac arrest survivors
Christoffer Rosén, Hans Rosén, Ulf Andreasson, et al.
Journal of Neuroinflammation
|
May 14, 2013
Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy
Aylin Yilmaz, Constantin T Yiannoutsos, Dietmar Fuchs, et al.
Journal of Neuroinflammation
|
January 26, 2019
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
Linn Hermansson, Aylin Yilmaz, Markus Axelsson, et al.
Brain Communications
|
November 7, 2022
The effect of vitamin B supplementation on neuronal injury in people living with HIV: a randomized controlled trial
Erika Tyrberg, Lars Hagberg, Lars-Magnus Andersson, et al.
BMC Infectious Diseases
|
April 23, 2016
Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study
Sofie Jespersen, Karin Kæreby Pedersen, Birgitta Anesten, et al.
Journal of Affective Disorders
|
October 17, 2020
Cost-effectiveness of an indicated preventive intervention for depression in adolescents: a model to support decision making
Richard Ssegonja, Filipa Sampaio, Iman Alaie, et al.
Journal of Neuroimmunology
|
February 6, 2025
Cerebrospinal fluid biomarkers associated with neurofilament light levels: A study in HIV disease
Enrico Ripamonti, Magnus Gisslén, Lars Hagberg, et al.
Plos One
|
February 14, 2014
Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients
Jan Jessen Krut, Tomas Mellberg, Richard W Price, et al.
BMJ Open
|
November 1, 2022
Digitally distributed Yoga Intervention in Breast Cancer Rehabilitation (DigiYoga CaRe): protocol for a randomised controlled trial
Emma Ohlsson Nevo, MiaLinn Arvidsson-Lindvall, Susanne Hellerstedt Börjeson, et al.
Virulence
|
July 21, 2016
No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau)
Jan J Krut, Richard W Price, Henrik Zetterberg, et al.
Page
of 14